These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21174624)

  • 1. Pharmacogenetics of psoriasis.
    O'Rielly DD; Rahman P
    Pharmacogenomics; 2011 Jan; 12(1):87-101. PubMed ID: 21174624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psoriasis].
    Guilhou JJ; Girard C
    Rev Prat; 2006 Dec; 56(19):2153-8. PubMed ID: 17416055
    [No Abstract]   [Full Text] [Related]  

  • 3. Conventional therapies for psoriasis.
    Rebora A
    Reumatismo; 2007; 59 Suppl 1():77-80. PubMed ID: 17828351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ustekinumab treats psoriasis refractory to seven conventional and biologic therapies.
    Rallis E; Verros CD
    Dermatol Online J; 2011 Apr; 17(4):14. PubMed ID: 21549089
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenomics and the resulting impact on psoriasis therapies.
    Foulkes AC; Warren RB
    Dermatol Clin; 2015 Jan; 33(1):149-60. PubMed ID: 25412789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential therapy using cyclosporine and acitretin for treatment of total body psoriasis.
    Short MW; Vaughan TK
    Cutis; 2004 Sep; 74(3):185-8. PubMed ID: 15499760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderate to severe plaque psoriasis - treatment with drugs of the classic scheme.
    Arnone M; Carvalho AVE; Takahashí MDF; Bernardo WM
    Rev Assoc Med Bras (1992); 2019 May; 65(4):530-534. PubMed ID: 31066805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized pustular psoriasis treated with ustekinumab.
    Storan ER; O'Gorman SM; Markham T
    Clin Exp Dermatol; 2016 Aug; 41(6):689-90. PubMed ID: 27333948
    [No Abstract]   [Full Text] [Related]  

  • 9. How genetic variation affects patient response and outcome to therapy for psoriasis.
    Woolf RT; Smith CH
    Expert Rev Clin Immunol; 2010 Nov; 6(6):957-66. PubMed ID: 20979559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood psoriasis: often favorable outcome.
    Prescrire Int; 2009 Dec; 18(104):275. PubMed ID: 20027717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The immunology of psoriasis: from basic research to the bedside].
    Gyulai R; Kemény L
    Orv Hetil; 2006 Nov; 147(46):2213-20. PubMed ID: 17396393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic sequential therapy of psoriasis: a new paradigm for improved therapeutic results.
    Koo J
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 2):S25-8. PubMed ID: 10459144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study.
    Ergun T; Seckin Gencosmanoglu D; Alpsoy E; Bulbul-Baskan E; Saricam MH; Salman A; Onsun N; Sarioz A
    J Dermatol; 2017 Jun; 44(6):630-634. PubMed ID: 27943425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodular melanoma arising in a patient treated with anti-tumor necrosis factor alpha antagonists.
    Carlesimo M; La Pietra M; Arcese A; Di Russo PP; Mari E; Gamba A; Orsini D; Camplone G
    Int J Dermatol; 2012 Oct; 51(10):1234-6. PubMed ID: 22416995
    [No Abstract]   [Full Text] [Related]  

  • 15. Patients with moderate-to-severe plaque psoriasis preferred oral therapies to phototherapies: a preference assessment based on clinical scenarios with trade-off questions.
    Opmeer BC; Heydendael VM; deBorgie CA; Spuls PI; Bossuyt PM; Bos JD; de Rie MA
    J Clin Epidemiol; 2007 Jul; 60(7):696-703. PubMed ID: 17573985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic therapy in the treatment of psoriasis: drugs of prebiological era].
    Kurilić M; Prpić-Massari L; Brajac I; Kastelan M
    Lijec Vjesn; 2010; 132(7-8):246-51. PubMed ID: 20857811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [News on psoriasis from the 2010 Dermatology Days in Paris].
    Boulinguez S
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 1):H1-5. PubMed ID: 21703458
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of adalimumab with traditional systemic antipsoriatic drugs - a report of 39 cases.
    Philipp S; Wilsmann-Theis D; Weyergraf A; Rotterdam S; Frambach Y; Gerdes S; Mössner R
    J Dtsch Dermatol Ges; 2012 Nov; 10(11):821-37. PubMed ID: 22934607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of topical and systemic treatment of psoriasis.
    Prieto-Pérez R; Cabaleiro T; Daudén E; Ochoa D; Román M; Abad-Santos F
    Pharmacogenomics; 2013 Oct; 14(13):1623-34. PubMed ID: 24088133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining systemic retinoids with biologic agents for moderate to severe psoriasis.
    Smith EC; Riddle C; Menter MA; Lebwohl M
    Int J Dermatol; 2008 May; 47(5):514-8. PubMed ID: 18412874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.